Study of co-encapsulated doxorubicin and curcumin poly(butyl cyanoacrylate) nanoparticles and reversion of multidrug resistance in MCF-7/ADR cell line

被引：0
|
作者：
Wu, Jun [1 ]
Duan, Jing-Hua [2 ]
机构：
[1] School of Chemical and Biological Engineering, Yancheng Institute of Technology, Yancheng, China
[2] Department of Pharmaceutical Sciences-Drug Development Division, College of Pharmacy, University of Kentucky, Lexington, KY 40536-0596, United States
来源：
Journal of Chemical and Pharmaceutical Research | 2013年 / 5卷 / 10期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：415 / 423
相关论文
共 50 条
  • [1] Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles
    Duan, Jinghua
    Mansour, Heidi M.
    Zhang, Yangde
    Deng, Xingming
    Chen, Yuxiang
    Wang, Jiwei
    Pan, Yifeng
    Zhao, Jinfeng
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 426 (1-2) : 193 - 201
  • [2] Identification of co-regulated genes associated with doxorubicin resistance in the MCF-7/ADR cancer cell line
    Miri, Ali
    Gharechahi, Javad
    Samiei Mosleh, Iman
    Sharifi, Kazem
    Jajarmi, Vahid
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] REVERSION OF MULTIDRUG RESISTANCE IN THE P-GLYCOPROTEIN POSITIVE BREAST CANCER CELL LINE(MCF-7/ADR) BY INTRODUCTION OF HAMMERHEAD RIBOZYME
    袁亚维
    张积仁
    陆长德
    祁国荣
    ChineseMedicalSciencesJournal, 1998, (01) : 24 - 28
  • [4] Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells
    Shieh, Ming-Jium
    Hsu, Chia-Yen
    Huang, Ling-Yi
    Chen, Hsuan-Ying
    Huang, Fei-Hong
    Lai, Ping-Shan
    JOURNAL OF CONTROLLED RELEASE, 2011, 152 (03) : 418 - 425
  • [5] Co-delivery of doxorubicin and quercetin by Janus hollow silica nanomotors for overcoming multidrug resistance in breast MCF-7/Adr cells
    Zhou, Haofei
    Yuan, Ye
    Wang, Zhexu
    Ren, Zexin
    Hu, Mixia
    Lu, JingKun
    Gao, Hongxia
    Pan, Cheng
    Zhao, Wenjie
    Zhu, Baohua
    COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2023, 658
  • [6] Investigation of multidrug resistance in docetaxel and doxorubicin-resistant MCF-7 cell lines
    Iscri, O. Darcansoy
    Kars, M. Demirel
    Gunduz, U.
    Arpaci, F.
    FEBS JOURNAL, 2006, 273 : 43 - 43
  • [7] Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells
    Zhong, Xin-Cheng
    Xu, Wen-Hong
    Wang, Zi-Ting
    Guo, Wang-Wei
    Chen, Jie-Jian
    Guo, Ning-Ning
    Wang, Tian-Tian
    Lin, Meng-Ting
    Zhang, Zhen-Tao
    Lu, Yi-Ying
    Yang, Qi-Yao
    Han, Min
    Xu, Dong-Hang
    Gao, Jian-Qing
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (09) : 1556 - 1564
  • [8] Preparation of psoralen polymer-lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells
    Huang, Qingqing
    Cai, Tiange
    Li, Qianwen
    Huang, Yinghong
    Liu, Qian
    Wang, Bingyue
    Xia, Xi
    Wang, Qi
    Whitney, John C. C.
    Cole, Susan P. C.
    Cai, Yu
    DRUG DELIVERY, 2018, 25 (01) : 1056 - 1066
  • [9] The Mechanisms of Autophagy Involved in the Effects of Everolimus (RAD001) on Overcoming Multidrug Resistance of Breast Cancer Cell Line MCF-7/ADR.
    Liu, Z-B
    Hou, Y. F.
    Xu, W-H
    Ling, H.
    Shao, Z-M
    CANCER RESEARCH, 2011, 71
  • [10] Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance: Evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells
    Wang, F
    Jiang, XP
    Yang, DC
    Elliott, RL
    Head, JF
    ANTICANCER RESEARCH, 2000, 20 (2A) : 799 - 808
12345